EBV-DC Vaccine - Epstein-Barr Virus Dendritic Cell Immunotherapy

Personalized dendritic cell vaccine targeting EBV-associated cancers including nasopharyngeal carcinoma, gastric cancer, and lymphoma. Activates immune system to fight virus-related tumors.

Dendritic cell vaccine specifically targeting Epstein-Barr Virus associated malignancies.

  • Nasopharyngeal Carcinoma
  • EBV-positive Gastric Cancer
  • EBV-associated Lymphoma
  • Other EBV-related tumors
  • Personalized immunotherapy approach
  • Targets root cause of EBV-driven cancers
  • Minimal systemic toxicity
  • Can be combined with other treatments
  • Long-term immune memory activation